These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31056242)

  • 1. Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246-1255].
    Ivanenkov YA; Machulkin AE; Garanina AS; Skvortsov DA; Uspenskaya AA; Deyneka EV; Trofimenko AV; Beloglazkina EK; Zyk NV; Koteliansky VE; Bezrukov DS; Aladinskaya AV; Vorobyeva NS; Puchinina MM; Ryabykh GK; Sofronova AA; Malyshev AS; Majouga AG
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1688. PubMed ID: 31056242
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Dipeptide inhibitors of the prostate specific membrane antigen (PSMA): A comparison of urea and thiourea derivatives" [Bioorganic Med. Chem. Lett. 42 (2021) 128044].
    Young JD; Ma MT; Eykyn TR; Andrew Atkinson R; Abbate V; Cilibrizzi A; Hider RC; Blower PJ
    Bioorg Med Chem Lett; 2021 Sep; 48():128231. PubMed ID: 34229996
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].
    Li P; Cai S; Zhao T; Xu L; Guan D; Li J; Zhou J; Zhang H
    Bioorg Med Chem Lett; 2022 Jan; 56():128502. PubMed ID: 34906405
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia" [Bioorg. Med. Chem. Lett. 60 (2022) 128587].
    Yin J; Zhao Y; He Q; Hai A; Peng Y; Zuo Z; Gao L; Song Z; Ke B
    Bioorg Med Chem Lett; 2022 Jul; 68():128765. PubMed ID: 35525630
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells.
    Lapidus RG; Tiffany CW; Isaacs JT; Slusher BS
    Prostate; 2000 Dec; 45(4):350-4. PubMed ID: 11102961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to 'Synthesis and biological evaluation of 7-methoxy-1-(3,4,5-trimethoxyphenyl)-4,5-dihydro-2H-benzo[e]indazoles as new colchicine site inhibitors' [Bioorgan. Med. Chem. Lett. 29 (2019) 2632-2634].
    Jiang J; Zhang Q; Guo J; Fang S; Zhou R; Zhu J; Chen X; Zhou Y; Zheng C
    Bioorg Med Chem Lett; 2021 Jun; 41():128015. PubMed ID: 33875347
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].
    Abdelall EKA; Abdelhamid AO; Azouz AA
    Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA
    Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
    Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK
    Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Design, solvent free synthesis, and antimicrobial evaluation of 1,4 dihydropyridines" [Bioorg. Med. Chem. Lett. 22 (2012) 6016-6023].
    Abdul R; Moturu TR; Babu JJ; Lakshmi KA
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2228. PubMed ID: 29773505
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives" [Bioorg. Med. Chem. Lett. 28 (14) (2018) 2481-2484].
    Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3129. PubMed ID: 30119958
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].
    Kahlon G; Lira R; Masvlov N; Pompa E; Brar N; Eagon S; Anderson MO; Andaya A; Chance JP; Fejzic H; Keniston A; Huynh N; Celis N; Vidal B; Trieu N; Rodriguez P; Mallari JP
    Bioorg Med Chem Lett; 2021 Apr; 37():127836. PubMed ID: 33588181
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Solid-phase synthesis of Biotin-S-Farnesyl-l-Cysteine, a surrogate substrate for isoprenylcysteine Carboxylmethyltransferase (ICMT)" [Bioorg. Med. Chem. Lett. 23 (2013) [5671-5673].
    Stevenson GI; Yong S; Fechner GA; Neve J; Lock A; Avery VM
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2575. PubMed ID: 30007572
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocyclyl-2,6-dicyanoanilines" [Bioorg. Med. Chem. Lett.] 27 (2017) 979-988].
    Pisal MM; Annadate RA; Athalye MC; Kumar D; Chavan SP; Sarkar D; Borate HB
    Bioorg Med Chem Lett; 2021 Jan; 32():127737. PubMed ID: 33307295
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Design, synthesis, anti-inflammatory activity and molecular docking of potential novel antipyrine and pyrazolone analogs as cyclooxygenase enzyme (COX) inhibitors" [Bioorgan. Med. Chem. Lett. 28(5) (2018) 952-957].
    El Sayed MT; El-Sharief MAMS; Zarie ES; Morsy NM; Elsheakh AR; Voronkov A; Berishvili V; Hassan GS
    Bioorg Med Chem Lett; 2022 Apr; 61():128626. PubMed ID: 35177303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.